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Patterns of Drug Prescription for
Japanese Cedar Pollinosis Using
a Clinical Vignette Questionnaire
Goro Takahashi1, Zensei Matsuzaki1, Takeo Nakayama2 and Keisuke Masuyama1
ABSTRACT
Background: Although prescribed drugs directly affect patient outcome, the variation in physicians’ attitudes
towards drug therapy for cedar pollinosis has not been quantitatively assessed. This research investigated the
prescription patterns of drugs for cedar pollinosis by ear, nose, and throat specialists (ENTs), general physi-
cians (GPs) and internal medicine doctors (IMs) in Yamanashi Prefecture, Japan.
Methods: A cross-sectional study was conducted by mailing questionnaires to 532 physicians in autumn
2006. The main part of the questionnaire constituted clinical vignettes of pollinosis cases with nasal and ocular
symptoms ranging from mild to severe. We requested that the physicians fill out prescription medications they
considered appropriate for each vignette.
Results: Responses from 172 physicians (32%) for six clinical vignettes were analyzed. The number of drugs
prescribed by ENTs was significantly higher than that by GPs and IMs for vignettes representing moderate to
severe cases (p < 0.004). The percentage of physicians who said they would prescribe nasal corticosteroid and
eye drops was higher in the ENT group compared to the other two groups in these vignettes. In terms of
second-generation antihistamines, no differences were observed between the three groups for all vignettes.
Conclusions: Our investigation suggested that, compared to ENTs, GPs and IMs have a lower tendency to
concomitantly prescribe drugs for localized treatment such as nasal corticosteroids and eye drops with oral
medication. There may be differences in prescription patterns of drugs for pollinosis between ENTs and non-
specialist physicians.
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INTRODUCTION
Allergic rhinitis is not a life-threatening illness, never-
theless patients suffer from highly uncomfortable
symptoms that disrupt the quality of everyday life and
productivity of academic or professional work.1 Symp-
toms of cedar pollinosis begin to appear around Feb-
ruary to March every year, and it is the most com-
mon type of seasonal allergic rhinoconjunctivitis in
Japan. According to a nationwide epidemiological
study, the prevalence of Japanese cedar pollinosis is
estimated to be 13%. However, recent studies based
on statistical analyses predict potential annual in-
creases in this figure.2,3 Such high figures demon-
strate that Japanese cedar pollinosis is indeed a large
problem in society.
In recent years, variation in the medical practice of
physicians has been the subject of research across
many clinical fields, from the perspective of the qual-
ity of healthcare.4-7 When considering the huge im-
pact cedar pollinosis has on society, it is important to
research the variations in medical practice for this
particular illness, especially with regard to the pat-
terns of drug prescription.
Currently, nasal corticosteroid drops are consid-
ered to be the first-line drug for patients with moder-
ate to severe allergic rhinitis.1 However, a cross-
sectional study has suggested that, in actuality, the
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prescription of nasal corticosteroids by general physi-
cians may be limited.8 According to Demoly et al.
whose research involved patients and general physi-
cians, oral antihistamines were prescribed for 92% of
the patients, whereas only 45% were prescribed nasal
steroids.9 Similarly, a patient survey conducted in Ja-
pan by Okuda et al. revealed a higher tendency of
general physicians to singly prescribe oral medica-
tion compared to otolaryngologists.10 Furthermore,
Van Hoecke et al. have shown with reference to the
Allergic Rhinitis and its Impact on Asthma (ARIA)
guideline that 30% of medicines prescribed by gen-
eral physicians for moderate or severe persistent al-
lergic rhinitis patients were considered as undertreat-
ment.11 This is a problem concerning compliance
with the guidelines for drug therapy. However, addi-
tional research conducted in, these previous studies
on clinically prescribed medication that are often in-
fluenced by many factors such as the patients’ clinical
conditions, personal values, healthcare environments,
medical resources and annual variance in antigen lev-
els suggest that it is not appropriate to interpret the
results simply as patterns of decision-making proc-
esses or patterns of drug prescription by individual
physicians.
To date, the prescription patterns of drugs for ce-
dar pollinosis have not been investigated. In this
study, we have investigated such prescription pat-
terns by Japanese physicians under the hypothesis
that general physicians depend less on nasal steroids
than otolaryngologists.
Traditionally, this type of research has been con-
ducted using methods such as assessments involving
simulated patients, or by reviewing medical records.
Recently, the validity and advantages of using clinical
vignettes for such research have been shown, and
this is now becoming a method of interest.12,13
The aim of this research is to compare the pre-
scription patterns of drugs for cedar pollinosis by ear,
nose, and throat specialists (ENTs), general physi-
cians (GPs) and internal medicine doctors (IMs) in
Yamanashi Prefecture, Japan.
METHODS
RESEARCH DESIGN, SETTINGS AND SUB-
JECTS
This research was designed as a cross-sectional study
carried out using mailed questionnaires. Subjects
were ENTs, GPs and IMs working in Yamanashi Pre-
fecture. The exact number of subjects was unknown
at the time of this study, although there were 59
ENTs and 491 physicians (total number of GPs and
IMs) in 2004 according to a report by the Ministry of
Health, Labour and Welfare.14
QUESTIONNAIRE DESIGN
The questionnaire was constructed by three ENTs. It
consisted of questions regarding 1) occupational
background of the subjects, 2) medical consultation
for allergic rhinitis, and 3) clinical vignettes for cedar
pollinosis. In principle, questionnaires were answered
anonymously and were self-completed. For each vi-
gnette, the most effective prescribed medication was
decided by the subjects and noted together with any
co-administered drugs or required medication.
RESEARCH METHODS
The names and addresses of 53 ENTs, 214 GPs and
265 IMs were found individually by searching
through phone books and the Internet. Question-
naires were mailed to them on October 10, 2006. Re-
minders were sent twice thereafter and the question-
naires were collected by November 10, 2006. This re-
search was conducted upon the approval of the Eth-
ics Review Board of the University of Yamanashi Hos-
pital.
STATISTICAL ANALYSIS
Background factors of the subjects were presented
descriptively. Responses for six clinical vignettes
were analyzed (Appendix). The names of prescribed
medication given for each vignette were categorized
and sorted into second-generation antihistamines,
oral steroids, antileukotrienes, other oral medication
(first-generation antihistamines, Chinese herbal
medicines, chemical mediator release inhibitors etc.),
nasal corticosteroid drops, non-steroidal anti-allergy
nasal drops (antihistamines, chromones etc.), nasal
vasoconstrictive agents and eye drops (steroids, anti-
histamines, chromones etc.). Fexsofenadine hydro-
chrorides and loratadins that were not accompanied
with a product leaflet containing information on pre-
cautions for vehicular driving were categorized as
non-sedative antihistamines, and analysis was carried
out accordingly.
The Kruskal-Wallis test was used to compare the
number of prescribed medications between the 3
groups of prescribers for each vignette. The signifi-
cance level was used according to the method by
Bonferroni at α = 0.008 (two-tailed). This test was car-
ried out for the null hypothesis: there was no differ-
ence in the number of prescribed medications be-
tween the 3 groups. For vignettes where the null hy-
pothesis was rejected, analysis was repeated using a
Mann-Whitney test between the 2 groups using a
two-tailed significance level of α = 0.004, again using
the Bonferroni method.
Furthermore, for each type of drug and for each vi-
gnette, both the percentage of physicians who pre-
scribed the drug and its 95% confidence intervals (or
one-sided 97.5% confidence interval) were used to
compare the 3 groups.
All statistical analyses were performed in Stata ver-
sion 9.2 (StataCorp, College Station, Tx, USA).
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Table 1 Characteristics of physicians included in the survey
IMGPENT
n＝55n＝72n＝45
Male, no. (%)
48 (87)68 (94)39 (87)
Years since graduation from medical school, median (IQR)
13 (8―20)25 (20―33)20 (14―27)
Physicians with a solo practice, no. (%)
3 (5)56 (78)24 (53)
Greatest number of polinosis patients per day examined in the Japanese cedar polinosis season of 2006, no. (%)
42 (76)0 (0)7 (16)1―10
10 (18)45 (63)16 (36)11―30
2 (4)25 (35)3 (7)31―50
1 (2)1 (1)19 (42)51―
0 (0)1 (1)0 (0)Unknown
Usefulness of Japanese practical guideline for AR in the Japanese cedar polinosis season of 2006, no. (%)
11 (20)11 (15)12 (27)Very useful
27 (49)51 (71)27 (60)Useful
4 (7)2 (3)5 (11)Neutral
0 (0)0 (0)0 (0)Not useful
0 (0)0 (0)0 (0)Not useful at al
13 (24)7 (10)1 (2)No experience of use
0 (0)1 (1)0 (0)Unknown
ENT, ear, nose, and throat specialists group; GP, general physicians group; IM, internal medicine doctors group; IQR, interquartile 
range.
RESULTS
Questionnaires were collected from 186 physicians
(response rate 36%). Fourteen questionnaires in total
were excluded from the analysis; this included 1
ENT, 2 GPs and 5 IMs who left the clinical vignettes
blank and 6 IMs who did not examine pollinosis pa-
tients during the 2006 cedar pollen season. Overall,
responses were received from 172 (32%) physicians
consisting of 45 ENTs, 72 GPs and 55 IMs, and were
included in the statistical analysis.
BACKGROUND OF SUBJECTS
The ENT and GP groups compared with the IM
group demonstrated a trend in seeing a larger num-
ber of cedar pollinosis patients each day. Further-
more, approximately 70% of subjects in all groups ap-
proved of the validity of the Practical Guideline for
the Management of Allergic Rhinitis in Japan (PG-
MARJ) (Table 1).15
REPORTED NUMBER OF PRESCRIBED DRUGS
FOR EACH VIGNETTE
The number of drugs reported by physicians that
they would prescribe was compared among the 3
groups for each vignette. The drugs that were in-
cluded in the count were oral drugs, nasal drops, eye
drops, co-administered drugs and other required
medication. For vignettes 3 to 6, the numbers given
by ENTs were significantly higher than for GPs and
IMs (p<0.004) (Fig. 1).
TRENDS IN DRUG PRESCRIPTION FOR EACH
TYPE OF DRUG
When comparing the percentage of physicians who
reported prescribing second-generation antihista-
mines using the 95% confidence interval, no differ-
ences could be observed among the 3 groups for all
vignettes (Fig. 2A).
The percentage of physicians who reported pre-
scribing non-sedative antihistamines was as high as
66% (95% CI: 51％―80%) in the ENT group and 64%
(95% CI: 52％―75%) in the GP group, compared with
40% (95% CI: 27％―54%) in the IM group for vignette 2
(data not shown). For all other vignettes, the percent-
age for non-sedative antihistamines was approxi-
mately 25% for all groups.
When the percentage of physicians who reported
prescribing nasal corticosteroid drops were com-
pared using a 95% confidence interval, an increasing
trend in percentages was found with increasing sever-
ity of symptoms in all 3 groups (Fig. 2B). In vignettes
4 to 6, this percentage was clearly higher in the ENT
group compared to the other 2 groups.
Comparison of the percentage of physicians who
prescribed eye drops using 95% confidence intervals
for vignettes 3 to 5 revealed that the percentage in
the ENT group was clearly much higher than in the
Takahashi G et al.
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Fig. 1 Box and whisker plots of the number of prescription drugs by ear, nose, and 
throat specialists (ENTs), general physicians (GPs), and internal medicine doctors 
(IMs) for each vignete. The vertical bars indicate the range from lower to upper adja-
cent values. The horizontal boundaries of the boxes represent the first and third 
quartiles. The thick bars in the boxes indicate medians. NS means, -not statisticaly 
significant. ＊, p＜0.004.
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other 2 groups (Fig. 2C).
For vignette 6, oral steroids were prescribed by
56% (95% CI: 40%−70%) of the ENT group and 45%
(95% CI: 33%−57%) of the GP group, but was lower at
21% in the IM group (95% CI: 11%−34%). For all other
vignettes, the percentage for oral steroids prescribed
was below 20% in all 3 groups.
As for the percentage of physicians prescribing an-
tileukotrienes and vasoconstrictive agents, there
were no significant differences among the 3 groups
for all vignettes.
POSSIBLE UNDERTREATMENT BY COMPARI-
SON WITH GUIDELINES
In addition, we analyzed the possibility of some pre-
scription patterns to be considered as undertreat-
ment, by referring to the ARIA or PG-MARJ medical
practice guidelines.1,15 The criteria for classifying
rhinitis and assessment of severity differs extensively
between the 2 guidelines. The cedar pollen season in
Japan lasts for approximately 2 months, and accord-
ing to the ARIA, most cedar pollinosis patients will be
classified as patients with persistent allergic rhinitis.
According to the PG-MARJ, however, the severity of
pollinosis is classified into 4 types: mild, moderate,
severe, or most severe, on the basis of a patient’s na-
sal symptoms and QOL grading. In the 2 guidelines,
it is recommended to use nasal steroids as the first-
choice either singularly or concomitantly for persis-
tent moderatesevere allergic rhinitis or moderate
severemost severe pollinosis. With reference to the
above, we analyzed the answers given for vignettes 4
to 6 which represent severe cases and identified
those that could potentially be considered as under-
treatment.
For vignette 4 which includes severe rhinorrhea
and sneezing symptoms, the prescription decided by
33% of physicians in the ENT group, 64% in the GP
and 65% in the IM groups could be considered as un-
dertreatment. For vignette 5 which includes severe
nasal congestion, possible undertreatment could be
identified in 13% of the ENT group, 37% of the GP
group and 57% of the IM group. For vignette 6 which
involves a case of severe overall symptoms, possible
undertreatment could be identified for 4% of the ENT
group, 25% of the GP group and 43% of the IM group
(Table 2).
Prescribing Pattern for Cedar Pollinosis
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Fig. 2 Percentage of physicians prescribing each type of 
drug for each vignete in the 3 groups by ear, nose, and 
throat specialists (ENTs), general physicians (GPs), and in-
ternal medicine doctors (IMs). The black circles indicate the 
simple percentages. The two-tailed bars represent the 95% 
confidence intervals of the percentages. The one-sided 
bars represent the 97.5% confidence intervals of the 
percentages. A: Second-generation antihistamines. B: Intra-
nasal corticosteroids. C: Antialergic eye drops.
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DISCUSSION
In this study we analyzed and compared for the first
time the prescription patterns of drugs for cedar polli-
nosis between physicians classified as ENTs, who are
specialists, and GPs and IMs through the use of clini-
cal vignettes. The research purpose for using clinical
vignettes was not to test the knowledge of physicians,
but to analyze how the physicians would prescribe
medication if they encountered such patients in real
life as described by the vignettes. Because responses
are likely to be biased in many ways, it is important to
analyze the responses given by a strictly defined
group of physicians rather than that of individuals.13
Recent studies have confirmed the validity of clinical
vignettes by comparing them with simulated patient
studies. Clinical vignettes are advantageous in that
they are more cost effective and practical compared
to simulated patients, and most of all, the problem of
case-mix that occurs during medical record reviews
can be regulated.12
In Japan, many cedar pollinosis patients consult
otolaryngologists and general physicians. According
to past research conducted on the trend of medical
consultation for cedar pollinosis patients, 40% con-
sulted otolaryngologists and 30% consulted general
physicians, and when questioned about the type of
medical institutions visited, 90% of patients consulted
clinics.10 Our questionnaire has confirmed that larger
numbers of cedar pollinosis patients consult ENTs
and GPs compared to IMs.
Our results suggest that the most obvious differ-
ences in the prescription patterns for cedar pollinosis
between ENTs, GPs and IMs are those of nasal corti-
costeroid drops and eye drops. In actuality, many fac-
tors including the patients themselves, features of the
medical institution and the amount of airborne pollen
present in a given season will affect the decision on
drug prescription. Therefore, information obtained
from our clinical vignettes is insufficient for use by
our respondents. It may be that our results here do
not represent the trends occurring in the prescription
of drugs in actual clinical settings. However, our re-
search does not focus on how well our results reflect
true clinical settings, but on discovering any differ-
ences in the prescription patterns of ENTs, GPs and
IMs for the same given clinical cases. What is impor-
tant here is the fact that the differences discovered in
the prescription patterns among the 3 groups are
clearly reflected by the differences in the percentage
of physicians prescribing nasal corticosteroid drops
and eye drops. In order to improve the quality of ce-
dar pollinosis treatment, it will be extremely neces-
sary to identify the reasons why GPs tend to be reluc-
tant in prescribing nasal corticosteroid drops and eye
drops to patients with moderatesevere symptoms.
This is intriguing since these GPs in particular exam-
ine a stable fraction of patients and understand the ef-
fectiveness of the guidelines. The reasons for reluc-
tance may be that they are afraid of systemic side-
effects triggered by steroids, or because patients who
consult GPs often have complications and are already
taking medication.8,11 Nevertheless, the clinical vi-
gnettes used here were designed so that complica-
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Table 2 Potential undertreatment of Japanese cedar polinosis according to the Alergic Rhinitis and its Impact on Asthma 
guideline or the Practical Guideline for the Management of Alergic Rhinitis in Japan15 recommendations
Vignete 6Vignete 5Vignete 4
IMGPENT IMGPENT IMGPENT 
n＝53n＝71n＝45n＝54n＝71n＝45n＝52n＝69n＝45
11 (21)7 (10)0 (0)14 (26)7 (10)1 (2)21 (40) 29 (42) 12 (27) AH
0 (0)0 (0)0 (0)3 (6)1 (1)0 (0)1 (2)0 (0)0 (0)AL
0 (0)3 (4)0 (0)0 (0)6 (9)2 (4)1 (2)6 (9)0 (0)OOt
0 (0)0 (0)0 (0)2 (4)0 (0)0 (0)0 (0)0 (0)0 (0)NsANS
0 (0)0 (0)0 (0)1 (2)0 (0)0 (0)0 (0)0 (0)0 (0)ND
1 (2)0 (0)2 (4)2 (4)3 (4)1 (2)2 (4)0 (0)0 (0)AH＋AL
3 (6)4 (6)0 (0)1 (2)2 (3)0 (0)1 (2)6 (9)1 (2)AH＋OOt
7 (13)4 (6)0 (0)8 (15)3 (4)1 (2)8 (15)2 (3)2 (4)AH＋NsANS
0 (0)0 (0)0 (0)0 (0)4 (6)1 (2)0 (0)1 (1)0 (0)AH＋ND
1 (2)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)AL＋ND
23 (43)18 (25)2 (4)31 (57)26 (37)6 (13)34 (65)44 (64)15 (33)Total
Number of physicians, (%); ENT, ear, nose, and throat specialists group; GP, general physicians group; IM, internal medicine doctors 
group; AH, second-generation antihistamines; AL, antileukotriens; OOt, other oral medications (e.g. first-generation antihistamines, 
herbal medications, etc); NsANS, nonsteroid antialergic nasal spray; ND, nasal decongestants. 
tions would not be included.
Furthermore, when using the medical practice
guidelines as a reference, physicians of all 3 groups,
including the ENTs who are specialists, may not be
fully aware of the severity of symptoms of allergic
rhinitis patients. In some cases, drug treatment initi-
ated by these physicians may be insufficient for the
control of symptoms. When the prescription patterns
suggested by the respondents were compared with
the prescriptions recommended by the ARIA guide-
line and PG-MARJ, a fair proportion of the suggested
prescriptions were considered as possible undertreat-
ment. The figures were 25 to 65% of GPs and IMs for
the 3 vignettes representing severe cases, and 33% of
even the ENT group for the vignette showing a se-
vere case with symptoms of rhinorrhea and sneezing.
The response rate of ENTs in this research was high
(85%), therefore it will be interesting to know the ex-
tent of divergence of the suggested prescription pat-
terns from the guidelines, bearing in mind that these
physicians are specialists. Nevertheless, the overall
degree of compliance with the guideline was higher
for ENTs compared to GPs or IMs with respect to the
vignettes representing severe symptoms.
Our study has several limitations. The first is that
our research was not conducted during the cedar pol-
len season. Decisions made by physicians and its pat-
terns may have been elicited more accurately by our
vignettes if the research was conducted immediately
after the end of the pollen season. Secondly, because
our research was based locally in Yamanashi Prefec-
ture, it is somewhat difficult to extend the implica-
tions of our results to a nationwide scale. Thirdly, this
research was limited by the low response rate of GPs
and IMs, who are non-specialist physicians. The moti-
vation of respondents directly influences the quality
of responses when using the clinical vignette method.
From this standpoint, although the response rate of
the GPs and IMs were 33% and 21%, respectively, it
can be suggested that those who kindly responded to
this complicated vignette method possessed suffi-
cient motivation. Thus, reliability of the results from
these physicians can be considered as high. Further-
more, it may be possible to speculate that GPsIMs
who did not respond, compared to those who did, are
consulting the guidelines insufficiently, are prescrib-
ing simple medication such as oral medicine and
have a higher potential for the undertreatment of pa-
tients. If these non-respondent physicians could be in-
cluded in the statistical analysis, the difference be-
tween the prescription patterns found between ENTs
and the other 2 groups might become clearer.
To conclude, our investigation of the drug prescrip-
tion patterns for cedar pollinosis in Yamanashi Pre-
fecture has shown that compared to ENTs, GPs and
IMs have a lower tendency to concomitantly pre-
scribe drugs for topical treatment such as nasal corti-
costeroids and eye drops with oral medication.
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APPENDIX
For the clinical vignettes shown below, please fill out
the names of medications that you feel are most ap-
propriate to prescribe.
A: Vignette 1 & 2
The amount of airborne cedar pollen is expected to
be normal this season. The patient is a 34-year-old
man who has visited with a major complaint of nasal
symptoms which started 5 days previously. The visit
was made 7 days after the beginning of cedar pollen
dispersal. He mentions that he did not experience
similar nasal symptoms at this time the previous year.
Following medical tests and examinations, he was
given a diagnosis of new-onset cedar pollinosis. He
has no history of other allergies.
Vignette 1
The occupation of this patient is a clerical worker.
The symptoms of rhinorrhea, sneezing and nasal con-
gestion are all mild, and no symptoms involve the
eyes.
Vignette 2
The occupation of this patient is a taxi driver. The
symptoms of rhinorrhea, sneezing and nasal conges-
tion are all mild, and no symptoms involve the eyes.
B: Vignettes 3−6
The amount of airborne cedar pollen is expected to
be normal this season. The patient is a 34-year-old
man who has visited with a major complaint of nasal
symptoms which started 7 days previously. The visit
was made 10 days after the beginning of cedar pollen
dispersal. The level of airborne cedar pollen is esti-
mated to reach its peak 1 week after his visit. He had
been experiencing similar nasal symptoms around
this time for the past several years, and apparently
had medication prescribed by other clinics, although
details are unknown. Following medical tests and ex-
aminations, he was given a diagnosis of cedar pollino-
sis. He has no history of other allergies.
Vignette 3
The occupation of this patient is a clerical worker.
The symptoms of rhinorrhea, sneezing and nasal con-
gestion are moderate, and symptoms involving the
eyes are mild.
Vignette 4
The occupation of this patient is a clerical worker.
The symptoms of rhinorrhea and sneezing are se-
vere, but nasal congestion is mild. Symptoms involv-
ing the eyes are mild.
Vignette 5
The occupation of this patient is a clerical worker.
The symptoms of rhinorrhea and sneezing are mild,
but nasal congestion is severe. Symptoms involving
the eyes are mild.
Vignette 6
The occupation of this patient is a clerical worker.
The symptoms of rhinorrhea, sneezing and nasal con-
gestion are all severe. Symptoms involving the eyes
are also severe.
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